Compare Vanguard S&P 500 ETF (VOO) vs GeneDx Holdings Corp (WGS) Price & Performance

Vanguard S&P 500 ETFTrade

GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Vanguard S&P 500 ETF vs GeneDx Holdings Corp — how do they compare? Vanguard S&P 500 ETF trades at $702.77, while GeneDx Holdings Corp trades at $86.53 (market cap $2.56B). The key difference: Vanguard S&P 500 ETF is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.

	VOO	WGS
Sector	Broad Market / Factor	Technology
52-Week High	$714.90	$167.51
52-Week Low	$580.93	$34.51
Market Cap	—	$2.56B
Enterprise Value	—	$2.60B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Vanguard S&P 500 ETF

VOO trades at $704.09, down 0.56% on the day, with a neutral technical signal and bullish moving averages. Support is firm near $701, while resistance sits at $707. The ETF remains a core S&P 500 holding, with recent news highlighting its tax efficiency versus gold ETFs and strong inflows amid record ETF launches in 2026.

Long-term outlook remains positive given historical S&P 500 performance, though risks include elevated market valuations and Fed policy uncertainty. The ETF offers broad market exposure, but investors face potential volatility from macroeconomic factors and high concentration in top AI-driven companies.

GeneDx Holdings Corp

WGS trades at $85.87, down 0.14% today, with a bullish technical signal from moving averages and support at $84. The company reported Q2 2026 revenue of $114.4M, beating estimates, and returned to adjusted profitability early. However, net income remains negative at -$106M for 2026, with high valuation multiples like EV/EBITDA of 161.17. Recent news highlights partnerships and product launches, such as the NPC GenomeComplete initiative with Beren Therapeutics.

Outlook is mixed: strong analyst buy consensus (90.9%) and institutional interest support upside, but profitability challenges and a class action lawsuit pose risks. Revenue growth and operational improvements are key catalysts, yet high debt-to-asset ratios and negative margins require monitoring for sustained recovery.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

VOO

Gold ETF gains taxed at 28%, nearly double S&P 500 ETF's 15% rate, costing investors thousands more.24/7 Wall Street · 12 hours agoBearish Four ETFs combine dividend income and total return to balance retirement income and growth risks.24/7 Wall Street · 1 day agoBullish S&P 500 moves with Fed rate hike odds; key 7620 level could signal buying opportunity after September CPI.Seeking Alpha · 2 days agoNeutral View details →

WGS

View details →

About Vanguard S&P 500 ETF

VOO is a foundational ETF that tracks the S&P 500 Index, providing exposure to 500 of the largest and most established companies in the United States. Renowned for its ultra-low expense ratio and tax efficiency, it serves as a core building block for long-term investors seeking to capture the total return of the U.S. large-cap market in a single, highly liquid vehicle.

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.